These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26409030)

  • 21. Electrocortical responses to NIMSTIM facial expressions of emotion.
    Smith E; Weinberg A; Moran T; Hajcak G
    Int J Psychophysiol; 2013 Apr; 88(1):17-25. PubMed ID: 23280304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of nalmefene on emotion processing in alcohol use disorder - A randomized, controlled fMRI study.
    Vollstädt-Klein S; Bumb JM; Otto A; Dinter C; Karl D; Koopmann A; Hermann D; Mann K; Kiefer F
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1442-1452. PubMed ID: 31740271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced orienting of attention in response to emotional gaze cues after oxytocin administration in healthy young men.
    Tollenaar MS; Chatzimanoli M; van der Wee NJ; Putman P
    Psychoneuroendocrinology; 2013 Sep; 38(9):1797-802. PubMed ID: 23562249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine.
    Strain EC; Walsh SL; Bigelow GE
    Psychopharmacology (Berl); 2002 Jan; 159(2):161-6. PubMed ID: 11862344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans.
    Eissenberg T; Greenwald MK; Johnson RE; Liebson IA; Bigelow GE; Stitzer ML
    J Pharmacol Exp Ther; 1996 Feb; 276(2):449-59. PubMed ID: 8632309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of an injection depot formulation of buprenorphine: placebo comparison.
    Sigmon SC; Wong CJ; Chausmer AL; Liebson IA; Bigelow GE
    Addiction; 2004 Nov; 99(11):1439-49. PubMed ID: 15500597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial.
    Ling W; Casadonte P; Bigelow G; Kampman KM; Patkar A; Bailey GL; Rosenthal RN; Beebe KL
    JAMA; 2010 Oct; 304(14):1576-83. PubMed ID: 20940383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alcohol acutely enhances decoding of positive emotions and emotional concern for positive stimuli and facilitates the viewing of sexual images.
    Dolder PC; Holze F; Liakoni E; Harder S; Schmid Y; Liechti ME
    Psychopharmacology (Berl); 2017 Jan; 234(1):41-51. PubMed ID: 27640999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid peptide receptor studies. 12. Buprenorphine is a potent and selective mu/kappa antagonist in the [35S]-GTP-gamma-S functional binding assay.
    Romero DV; Partilla JS; Zheng QX; Heyliger SO; Ni Q; Rice KC; Lai J; Rothman RB
    Synapse; 1999 Nov; 34(2):83-94. PubMed ID: 10502307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B; Christoph T; Strassburger W; Friderichs E
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjects.
    La Vincente SF; White JM; Somogyi AA; Bochner F; Chapleo CB
    Clin Pharmacol Ther; 2008 Jan; 83(1):144-52. PubMed ID: 17568402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial.
    Fava M; Memisoglu A; Thase ME; Bodkin JA; Trivedi MH; de Somer M; Du Y; Leigh-Pemberton R; DiPetrillo L; Silverman B; Ehrich E
    Am J Psychiatry; 2016 May; 173(5):499-508. PubMed ID: 26869247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxytocin and reduction of social threat hypersensitivity in women with borderline personality disorder.
    Bertsch K; Gamer M; Schmidt B; Schmidinger I; Walther S; Kästel T; Schnell K; Büchel C; Domes G; Herpertz SC
    Am J Psychiatry; 2013 Oct; 170(10):1169-77. PubMed ID: 23982273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of opioid receptor stimulation and blockade on touch pleasantness: a double-blind randomised trial.
    Løseth GE; Eikemo M; Leknes S
    Soc Cogn Affect Neurosci; 2019 May; 14(4):411-422. PubMed ID: 30951167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopaminergic and opioidergic regulation during anticipation and consumption of social and nonsocial rewards.
    Korb S; Götzendorfer SJ; Massaccesi C; Sezen P; Graf I; Willeit M; Eisenegger C; Silani G
    Elife; 2020 Oct; 9():. PubMed ID: 33046213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality.
    Harris DS; Mendelson JE; Lin ET; Upton RA; Jones RT
    Clin Pharmacokinet; 2004; 43(5):329-40. PubMed ID: 15080765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rejection sensitivity, interpersonal rejection, and attention for emotional facial expressions.
    Kraines MA; Kelberer LJA; Wells TT
    J Behav Ther Exp Psychiatry; 2018 Jun; 59():31-39. PubMed ID: 29136514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute administration of buprenorphine in humans: partial agonist and blockade effects.
    Walsh SL; Preston KL; Bigelow GE; Stitzer ML
    J Pharmacol Exp Ther; 1995 Jul; 274(1):361-72. PubMed ID: 7542336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An inpatient study of the effects of buprenorphine on cigarette smoking in men concurrently dependent on cocaine and opioids.
    Mutschler NH; Stephen BJ; Teoh SK; Mendelson JH; Mello NK
    Nicotine Tob Res; 2002 May; 4(2):223-8. PubMed ID: 12028854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anger management style and emotional reactivity to noxious stimuli among chronic pain patients and healthy controls: the role of endogenous opioids.
    Bruehl S; Burns JW; Chung OY; Quartana P
    Health Psychol; 2008 Mar; 27(2):204-14. PubMed ID: 18377139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.